|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
(SoCalBio)
enany@socalbio.org
www.socalbio.org
| June 8, 2010  |
| Analysis | Report: Reimbursement Codes Block Innovative Surgical Techniques
Commercialization costs and bureaucratic red tape keep device makers from bringing more advanced minimally invasive surgical techniques into the spectrum of care, according to a report from design and engineering firm Cambridge Consultants.... Read more |
SoCalBio Golf Classic
| SoCalBio/Image 2000 Golf Classic
(ending with with reception and dinner)
Old Ranch Country Club in Seal Beach
Thanks to Title Sponsor
Join your medtech and biotech colleagues and friends for a great day of golf in one of the exquisite courses in Southern California while you show your support for the bioscience industry, the Multiple Sclerosis Society and SoCalBio.
|
RSVP for Mixers and Executive Forums
| June 22, 11:00 AM - 2:00 PM
SoCalBio Luncheon and Roundtable Discussion for Cardiovascular Company Executives
DevicePharm (Irvine, CA)
The luncheon & Roundtable is solely for solid peer-to-peer information exchange and debate. The roundtable is open to SoCalBio member companies and invited executives affiliated with non-member companies.
Click to RSVP
(Only executives in cardiovascular companies)
****************************** ***************************
June 28, 5:00 - 8:30 PM
Post Golf Tournament Cocktail Reception and Dinner
Old Ranch Country Club in Seal Beach
| Dr. Leslie Weiner |  |
The SoCalBio/Image 2000 Golf Classic will conclude with a cocktail reception and dinner. This post-tournament mixer will feature Dr. Leslie Weiner of the USC Keck School of Medicine who will address attendees about new multiple sclerosis treatment modalities. You don't need to sign up for the tournament to be able to participate in this dinner.
RSVP to Attend the Dinner
(Only if you are NOT a tournament player. This dinner is already included in the players' package of benefits)
July 23, 8:00 AM to 12:00 Noon
SoCalBio Open House
Wilshire Grand Hotel in Downtown Los Angeles
Learn how SoCalBio's Group Purchasing Program can slow your company's burn rate and cut down the cost of doing business; and get detailed insight into how SoCalBio can help your organization succeed.
RSVP Now
|
New Initiatives
| USC Stevens Launches a New Grant Program Called "Ideas Empowered" to Spur Innovation The Ideas Empowered program aims to identify the most exciting and game-changing ideas imagined in the minds of USC researchers. The program supports not only the ideas, but also the innovators. Through mentoring and coaching, connections to resources, and funding for proof-of-concept experiments and prototype development, the program reduces development and investment risks surrounding promising early discoveries... Learn more |
Intellectual Property
| Clarient Receives Patents for Taxane Biomarker The Aliso Viejo-based company announced that the United Kingdom Patent Office has granted a U.K. patent on the Company's TLE3 biomarker, a marker which may be used to predict which cancer patients will respond favorably to taxane therapy... Read more |
Clinical Data
| Immunocellular Therapeutics' Brain Cancer Vaccine Extends Survival Rate in Small Trial
The Woodland Hills-based Immunocellular Therapeutics announced that its brain cancer vaccine yielded positive results in a small Phase I clinical trial. The overall patient survival rate was 100 percent at one year and 80 percent at two years, compared to a historical survival rate with standard therapy of 61.1 percent at one year and 26.5 percent at two years. ICT-107 is a dendritic cell-based vaccine that uses the patient's own cells to provoke a disease-fighting response... Read more
Amgen Bone Drug Cuts Prostate Cancer Bone Problems
A third pivotal trial of Amgen Inc's (AMGN.O) denosumab found that it significantly delayed the likelihood of suffering fractures and other bone complications in men with advanced prostate cancer compared with current therapy.... Read more
Abraxane Outperforms Taxol in Lung Cancer Study
Abraxis Bioscience Inc said its cancer drug Abraxane outperformed the generic drug Taxol in patients with non-small cell lung cancer, without requiring patients to take steroids or antihistamines. The company said 33 percent of patients who got Abraxane in combination with the chemotherapy drug carboplatin responded to it, compared with 25 percent of patients who got chemotherapy combined with Taxol, a drug developed by Bristol-Myers Squibb (BMY.N) that is available generically as paclitaxel ... Read more
|
CE Mark
|  Millennium Dental Technologies Wins CE Marking for PerioLase MVP-7 Digital Dental Laser for the Treatment of Gum Disease Manufactured by the Cerritos-based Millennium Dental Technologies, the PerioLase MVP-7 is a 6-watt free-running variable pulsed Nd:YAG dental laser featuring digital technology and seven pulse durations. The CE marking certifies that the product has met European Union health and safety standards and is approved for sale within EU countries and members of the European Free Trade Association... Read more |
| Jobs Available | Dentatek (Laguna Niguel)
Dentatek Corporation has a novel technology to clean root canals that promises to revolutionize endodontic therapy. The company is seeking to fill the following positions:
- Quality Manager
- Director of Regulatory Affairs
|
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
IntriMed designs and manufactures ultra-precision mechanical components critical to medical device functionality...
